-
Low testosterone production, known clinically as hypogonadism, appears to be common
complication of type 2 diabetes, affecting one in three diabetic men. Hypogonadism is known
to be associated with decreased muscle mass, increased fat mass, increased inflammation and
decreased fertility. In this grant, the investigators propose to study the effects of having
low testoste...
Location: Millard Fillmore Gates Hospital
Status: Recruiting
» Read more
-
This study is designed to assess the incidence of cardiovascular events occurred within an
12 month follow up period in type 2 diabetic patients with either high risk of
cardiovascular disease (CVD) or history of coronary artery disease (CAD) or stroke.
Location: Weiqing Wang
Status: Recruiting
» Read more
-
The purpose of this study is investigating the clinical characteristics of newly diagnosed,
drug naïve type 2 diabetic patients according to insulin secretion and insulin resistance.
Location: GSK Investigational Site
Status: Recruiting
» Read more
-
This is a biomarker exploratory study which is designed to investigate the function and
oxidation of the high density lipoprotein (HDL) (the good cholesterol) in patients with type
2 diabetes mellitus treated with Vitamin E versus placebo and segregated by the type of the
Haptoglobin protein they have in their blood.
Location: Laboratory of Vascular Medicine, Technion Facul...
Status: Recruiting
» Read more
-
The objective of this randomized controlled trial was to evaluate the effects of two
different physical exercise programs aimed at long-term lifestyle changes in physical
activity in patients with Type 2 Diabetes, with glucose metabolism evaluated by HbA1c as the
primary outcome.
Location: Department of Endocrinology, Hospital of Southw...
Status: Completed
» Read more
-
To study the effects of pioglitazone on the steroidogenic enzyme axis in eugonadal men with
type 2 diabetes mellitus.
Location: PGIMER
Status: Recruiting
» Read more
-
The purpose of this study is to explore whether the novel therapy of type 2 diabetes,
vildagliptin, which inhibits dipeptidyl peptidase-4 (DPP-4), affects glucagon
counterregulation during hypoglycemia in insulin-treated patients with type 2 diabetes.
Vildagliptin is given, together with the on-going insulin therapy, for one month, whereafter
hypoglycemia is induced unde...
Location: Lund University
Status: Not yet recruiting
» Read more
-
To characterize type 2 diabetic patients with initial alterations of diabetic retinopathy
(DR) based on 3 different phenotypes previously identified and different patterns of
progression in order to correlate this data with genetic information.
Location: AIBILI - Clinical Trials Center
Status: Enrolling by invitation
» Read more
-
Glucose-induced insulin secretion is often diminished in hyperglycaemic patients with type 2
diabetes. The investigators examined, whether chronic basal insulin treatment with insulin
glargine lead to improvements in glucose-induced insulin secretion.
Location: Department of Medicine I; University Hospital S...
Status: Completed
» Read more
-
Type 2 diabetes mellitus is a chronic disease with severe long-term health consequences. In
patients with type 2 diabetes mellitus who are also morbidly obese, an abundance of clinical
evidence exists showing that significant clinical improvement in their diabetes occurs
following certain types of bariatric, or weight loss, surgical procedures. There is
additional data...
Location: McKenzie Health System
Status: Not yet recruiting
» Read more